Federal agency roles in cancer drug development from preclinical research to new drug approval (Record no. 85880)

000 -LEADER
fixed length control field 01510nam a2200349Ia 4500
001 - CONTROL NUMBER
control field vtls003178708
003 - CONTROL NUMBER IDENTIFIER
control field MY-SjTCS
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20200226111809.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m u
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cn|||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100712s2005 dcu ss 000 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0309096391
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10078111
039 #9 - LEVEL OF BIBLIOGRAPHIC CONTROL AND CODING DETAIL [OBSOLETE]
-- 201007121459
-- VLOAD
040 ## - CATALOGING SOURCE
Original cataloging agency CaPaEBR
Transcribing agency CaPaEBR
050 14 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC271.C5
Item number N49 2005eb
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Newhouse, Joseph P.
245 10 - TITLE STATEMENT
Title Federal agency roles in cancer drug development from preclinical research to new drug approval
Medium [electronic resource] :
Remainder of title the National Cancer Institute and the Food and Drug Administration /
Statement of responsibility, etc. Joseph P. Newhouse, John Mendelsohn, Hellen Gelband and Roger Herdman.
250 ## - EDITION STATEMENT
Edition statement 3rd ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Washington, D.C. :
Name of publisher, distributor, etc. National Academy Press,
Date of publication, distribution, etc. c2005.
300 ## - PHYSICAL DESCRIPTION
Extent 61 p.
529 ## -
-- TSLHHL
533 ## - REPRODUCTION NOTE
Type of reproduction Electronic reproduction.
Place of reproduction Palo Alto, Calif. :
Agency responsible for reproduction ebrary,
Date of reproduction 2009.
Note about reproduction Available via World Wide Web.
-- Access may be limited to ebrary affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic agents
General subdivision Development.
9 (RLIN) 26709
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Public administration
Geographic subdivision United States.
9 (RLIN) 24541
655 #7 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
Source of term local
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mendelsohn, John.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gelband, Hellen.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Herdman, Roger.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element ebrary, Inc.
9 (RLIN) 25628
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://ezproxy.taylors.edu.my/login?url=http://site.ebrary.com/lib/taylorscollege/Doc?id=10078111
Public note An electronic book accessible through the World Wide Web; click to view
999 ## - SYSTEM CONTROL NUMBERS (KOHA)
Koha biblionumber 85880
Koha biblioitemnumber 85880

No items available.